NCT01542138View on ClinicalTrials.gov

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Hyperpigmentation
Interventions
DRUG

Desonide

Once-a-day applying on axillar hyperpigmentation for 9 weeks

DRUG

Niacinamide

Once-a-day applying on axillar hyperpigmentation for 9 weeks

DRUG

Placebo

Humectant placebo cream

Trial Locations (1)

78210

"Dermatology Department. Hospital Central Dr. Ignacio Morones Prieto", San Luis Potosí City

All Listed Sponsors
collaborator

"Hospital Central Dr. Ignacio Morones Prieto"

OTHER

lead

Universidad Autonoma de San Luis Potosí

OTHER

NCT01542138 - Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation | Biotech Hunter | Biotech Hunter